Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension.

British Journal of Clinical Pharmacology

Volumn 14, Issue 2 S, 1982, Pages 127S-131S

  Weinberger, MH ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; HYDROCHLOROTHIAZIDE;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMPARISON; DRUG THERAPY; HUMAN; HYPERTENSION; HYPERURICEMIA; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALAISE; MYALGIA; ORAL DRUG ADMINISTRATION; PARESTHESIA; RANDOMIZED CONTROLLED TRIAL; RASH; THERAPY;

BLOOD; BLOOD PRESSURE; CAPTOPRIL; COMPARATIVE STUDY; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGE; PROLINE;

EID: 0020368126     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1982.tb02069.x     Document Type: Article

References (6)

1. Converting‐enzyme‐inhibitor with an orally active compound in hypertensive men
2. Clinical experience with blockade of the renin‐angiotensin‐aldosterone system by an oral converting‐enzyme‐inhibitor (SQ 14225, captopril) in hypertensive patients
3. Antihypertensive effect of the oral angiotensin converting‐enzyme‐inhibitor SQ 14225 in man
4. Acute and chronic effects of the angiotensin‐converting‐enzyme inhibitor captopril in severe hypertension
5. Clinical experience with captopril in the treatment of severe drug‐resistant hypertension
6. Role of sympathetic nervous system activity in the blood pressure response to long‐term captopril therapy in severely hypertensive patients